Abstract
Healthcare Resource Utilization and Costs in Patients with Relapsed and Refractory Diffuse Large B-Cell Lymphoma: A U.S. Real-World Observational Study
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have